Vital LB

Optimal Threshold of Cardiac Troponin I Concentration for Risk Stratification

 In Naturopathic News

Node Smith, ND

High Sensitivity Cardiac Troponin I Testing to Determine Likelihood of Current and Future Cardiac Events

A global study on the use of high-sensitivity cardiac troponin I testing in the evaluation of patients with chest pain offers a definitive threshold for determining likelihood of current and future cardiac event.1 The current use of high-sensitivity cardiac troponin I uses a threshold of 5 ng/L to place patients in a low risk category, however the optimal threshold has been undetermined, meaning patients with a troponin level under 5 ng/L are often kept under observation. The purpose of the current study was to look at a large enough sample to determine whether patients with a troponin under 5 ng/L could be considered low risk enough to warrant discharge. The results of the study were favorable to this effect and there has been a call to revise current acute coronary syndrome screening guidelines and protocols.

Troponin I Study

The study looked at 104 articles from 9 different countries. The meta-analysis included 22,457 patients with a mean age of 62 years, 41.5% women who were admitted to the hospital with concerns of acute coronary syndrome. It was found that in 49% had troponin I concentrations of less than 5 ng/L at the time of presentation (11,012 patients). Of this number, there were 59 patients who were indeed having a myocardial infarction, and 1 patient who had a cardiac event within 30 days. There were no cardiac deaths at 30 days of any patients presenting with troponin I concentration of under 5 ng/L. The negative predictive value of a 5 ng/L threshold for high-sensitivity troponin I was calculated to be 99.5%. The negative predictive value for cardiac death up to a year was 99.9% (there were 7 deaths within a year – all after 30 days – within sub-threshold group).

A Call to Revise Current Guidelines has been Issued

The conclusion of the study is that “among patients with suspected acute coronary syndrome, a high-sensitivity cardiac troponin I concentration of less than 5 ng/L identified those at low risk of myocardial infarction or cardiac death within 30 days.” The clinical utility and cost-effectiveness of this approach to risk stratification is still under investigation, however, a call to revise current guidelines has been issued.


  1. Chapman AR, Lee KK, Mcallister DA, et al. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. 2017.
Image Copyright: <a href=’’>molekuul / 123RF Stock Photo</a>

Node Smith, ND, is a naturopathic physician in Portland, OR and associate editor for NDNR. He has been instrumental in maintaining a firm connection to the philosophy and heritage of naturopathic medicine among the next generation of docs. He helped found the first multi-generational experiential retreat, which brings elders, alumni, and students together for a weekend camp-out where naturopathic medicine and medical philosophy are experienced in nature. Four years ago he helped found the non-profit, Association for Naturopathic ReVitalization (ANR), for which he serves as the board chairman. ANR has a mission to inspire health practitioners to embody the naturopathic principles through experiential education. Node also has a firm belief that the next era of naturopathic medicine will see a resurgence of in-patient facilities which use fasting, earthing, hydrotherapy and homeopathy to bring people back from chronic diseases of modern living; he is involved in numerous conversations and projects to bring about this vision.

Recent Posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Contact Us

How can we help you?

Not readable? Change text. captcha txt

Start typing and press Enter to search